Synthetic Phages as a New Front in AMR

Synthetic biology is revolutionizing bacteriophage therapy in 2024 by enabling the creation of synthetic phages that can be engineered to target specific antibiotic-resistant bacteria. Traditional phage therapies rely on naturally occurring phages, but synthetic phages can be modified to enhance their ability to bind to and destroy even the most resistant bacterial strains.

This approach has generated significant interest as synthetic phages can be customized for specific infections, potentially offering a tailored solution for difficult-to-treat conditions. Trials are already underway to test these synthetic phages in treating infections that have not responded to antibiotics. The flexibility of synthetic biology could expand the range of bacteria that can be targeted, opening new frontiers in the fight against antimicrobial resistance.